Your browser doesn't support javascript.
loading
Recording and reporting of ultra-high dose rate "FLASH" delivery for preclinical and clinical settings.
Tobias Böhlen, Till; Psoroulas, Serena; Aylward, Jack D; Beddar, Sam; Douralis, Alexandros; Delpon, Grégory; Garibaldi, Cristina; Gasparini, Alessia; Schüler, Emil; Stephan, Frank; Moeckli, Raphaël; Subiel, Anna.
Affiliation
  • Tobias Böhlen T; Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
  • Psoroulas S; Center for Proton Therapy, Paul Scherrer Institute, Villigen PSI, Switzerland; Klinik für Radio-Onkologie, UniversitätsSpital Zürich, Switzerland.
  • Aylward JD; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK; Medical Physics, School of Applied Sciences, University of the West of England, Bristol, UK
  • Beddar S; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Douralis A; National Physical Laboratory, Hampton Road, Teddington TW11 0LW, UK.
  • Delpon G; Institut de Cancérologie de l'Ouest, Medical Physics Department, Saint-Herblain, France; Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, Nantes, France.
  • Garibaldi C; IEO, Unit of Radiation Research, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Gasparini A; CORE, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Medical Physics Department, Iridium Netwerk, Wilrijk, Belgium.
  • Schüler E; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Stephan F; Deutsches Elektronen-Synchrotron DESY, Platanenallee 6, 15738 Zeuthen, Germany.
  • Moeckli R; Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland. Electronic address: raphael.moeckli@chuv.ch.
  • Subiel A; National Physical Laboratory, Hampton Road, Teddington TW11 0LW, UK; University College London, Gower Street, London WC1E 6BT, UK. Electronic address: anna.subiel@npl.co.uk.
Radiother Oncol ; 200: 110507, 2024 Nov.
Article in En | MEDLINE | ID: mdl-39245070
ABSTRACT
Treatments at ultra-high dose rate (UHDR) have the potential to improve the therapeutic index of radiation therapy (RT) by sparing normal tissues compared to conventional dose rate irradiations. Insufficient and inconsistent reporting in physics and dosimetry of preclinical and translational studies may have contributed to a reproducibility crisis of radiobiological data in the field. Consequently, the development of a common terminology, as well as common recording, reporting, dosimetry, and metrology standards is required. In the context of UHDR irradiations, the temporal dose delivery parameters are of importance, and under-reporting of these parameters is also a concern.This work proposes a standardization of terminology, recording, and reporting to enhance comparability of both preclinical and clinical UHDR studies and and to allow retrospective analyses to aid the understanding of the conditions which give rise to the FLASH effect.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Dosage Limits: Animals / Humans Language: En Journal: Radiother Oncol Year: 2024 Document type: Article Affiliation country: Suiza Country of publication: Irlanda

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Dosage Limits: Animals / Humans Language: En Journal: Radiother Oncol Year: 2024 Document type: Article Affiliation country: Suiza Country of publication: Irlanda